Thanks to the combined work of AIM and the Alzheimer’s Association, the federal government has committed to a goal to prevent and effectively treat Alzheimer's disease by 2025. But achieving this goal requires a significant research commitment at the National Institutes of Health (NIH).
AIM has worked with the Alzheimer’s Association to propel the U.S. government to rise to this challenge, resulting in nearly tripling Alzheimer’s research funding in just five years - including a historic $400 million increase for Alzheimer’s research at the NIH in 2017. Today, funding for Alzheimer’s and dementia related research at the National Institutes of Health (NIH) is $1.4 billion. In July 2017, the House Appropriations Committee approved an additional $400 million for fiscal year 2018 and the Senate is expected to act in the coming months.
Yet despite this progress, we still have much further to go.
That’s why AIM works to grow bipartisan support in Congress to secure additional federal research funding for the NIH. AIM, the Alzheimer’s Association, and our advocates are currently asking for Congress to approve a $414 million increase for the government’s 2018 budget. This is consistent with the Alzheimer's Bypass Budget issued by the National Institutes of Health (NIH).
Urge your Members of Congress to invest in Alzheimer’s disease research.